| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 Apr 2026 | 2 Apr 2026 |
| Board Meeting Outcome For Appointment Of Company Secretary And Compliance Officer | ||
| Board Meeting | 19 Mar 2026 | 19 Mar 2026 |
| Outcome of Board Meeting for approval via Postal Ballot for the appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613) as the Chairman and Managing Director of the Company. | ||
| Board Meeting | 10 Feb 2026 | 2 Feb 2026 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results for the quarter ended December 31, 2025 and designation of Director as Chairman & Managing Director. Outcome of Board Meeting dated 10.02.2026. (As Per BSE Announcement Dated on: 10/02/2026) | ||
| Board Meeting | 12 Nov 2025 | 5 Nov 2025 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited Standalone Financial Results For The quarter and half year ended September 30 2025. We hereby inform you that the Board of Directors of the Company at its meeting held today has approved the Unaudited Standalone financial results of the Company for the quarter and half year ended on 30th September, 2025 (As Per BSE Announcement Dated on 12.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June 2025 Adline Chem Lab Limited has informed BSE that the Board of Directors of the Company has considered and approved Unaudited Standalone Financial Results for the quarter ended June 30, 2025. (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 13 Jun 2025 | 6 Jun 2025 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2025 inter alia to consider and approve the agenda as enclosed Outcome of Board Meeting enclosed herewith (As per BSE Announcement Dated on 13/06/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.